Erlotinib-associated alopecia in a lung cancer patient

被引：5

作者：

Costa, Daniel B. ^{[1
]}

Kobayashi, Susumu ^{[1
]}

Schumer, Susan T. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02114 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 12期

关键词：

alopecia; erlotinib; skin; epidermal growth factor receptor; non-small cell lung cancer; tyrosine kinase inhibitor; gefitinib;

D O I：

10.1097/JTO.0b013e31815ba7f9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1136 / 1138

页数：3

共 5 条

[1] Dermatologic side effects associated with the epidermal growth factor receptor inhibitors [J].

Agero, Anna Liza C. ;

Dusza, Stephen W. ;

Benvenuto-Andrade, Cristiane ;

Busam, Klaus J. ;

Myskowski, Patricia ;

Halpern, Allan C. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) :657-670

[2]

Costa DB, 2006, LUNG CANCER, V53, P123, DOI 10.1016/j.lungcan.2006.04.004

[3]

Hansen LA, 1997, AM J PATHOL, V150, P1959

[4] EXPRESSION OF A DOMINANT-NEGATIVE MUTANT OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE EPIDERMIS OF TRANSGENIC MICE ELICITS STRIKING ALTERATIONS IN HAIR FOLLICLE DEVELOPMENT AND SKIN-STRUCTURE [J].

MURILLAS, R ;

LARCHER, F ;

CONTI, CJ ;

SANTOS, M ;

ULLRICH, A ;

JORCANO, JL .

EMBO JOURNAL, 1995, 14 (21) :5216-5223

[5] Cutaneous side-effects of kinase inhibitors and blocking antibodies [J].

Robert, C ;

Soria, JC ;

Spatz, A ;

Le Cesne, A ;

Malka, D ;

Pautier, P ;

Wechsler, J ;

Lhomme, C ;

Escudier, B ;

Boige, V ;

Armand, JP ;

Le Chevalier, T .

LANCET ONCOLOGY, 2005, 6 (07) :491-500

← 1 →